A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function

NCT07715149 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Participants
Hepatic Impairment (HI)

Interventions

DRUG: D-2570

Sponsor

InventisBio Co., Ltd